46 inmates, 43 staffers of three jails in Delhi test positive for COVID-19

According to data shared by the jail authorities, 46 inmates tested positive till Sunday — 29 inmates in Tihar and the remaining 17 in Mandoli jail.

PTI

January 10, 2022 / 08:38 IST

Ten other accused persons are involved in the crime. (Representational image)

Forty-six inmates and 43 staffers of three jails in Delhi have tested positive for COVID-19, officials said on Monday. "All the infected inmates as well as staffers have been under isolation and are recovering," said a senior jail official.

According to data shared by the jail authorities, 46 inmates tested positive till Sunday — 29 inmates in Tihar and the remaining 17 in Mandoli jail.

Among the 43 infected staffers, 25 are from Tihar, 12 from Rohini jail and six from Mandoli jail. As part of the steps taken to contain the spread of the viral disease in Tihar, Mandoli and Rohini jail complexes, prison dispensaries have been turned into Covid care centres.

An oxygen plant in Tihar will be functional soon, officials said. Many medical isolation cells have been set up for inmates showing slight symptoms of COVID-19, they said.

Those who test positive but are asymptomatic will be kept in separate isolation cells within the same jail. The 120-bed hospital in Tihar and the 48-bed facility in Mandoli have been converted into Covid Health Centres.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show